» Articles » PMID: 36794825

The Trends and Determinants of Seasonal Influenza Vaccination After Cardiovascular Events in Canada: a Repeated, Pan-Canadian, Cross-sectional Study

Overview
Specialty Public Health
Date 2023 Feb 16
PMID 36794825
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Annual influenza vaccination is recommended for individuals with a history of cardiovascular disease (CVD) events. We aimed to examine (1) the time trends for influenza vaccination among Canadians with a CVD event history between 2009 and 2018, and (2) the determinants of receiving the vaccination in this population over the same period.

Methods: We used data from the Canadian Community Health Survey (CCHS). The study sample included respondents from 2009 to 2018 who were 30 years of age or more with a CVD event (heart attack or stroke) and who indicated their flu vaccination status. Weighted analysis was used to determine the trend of vaccination rate. We used linear regression analysis to examine the trend and multivariate logistic regression analysis to examine determinants of influenza vaccination, including sociodemographic factors, clinical characteristics, health behaviour and health system variables.

Results: Over the study period, in our sample of 42 400, the influenza vaccination rate was overall stable around 58.9%. Several determinants for vaccination were identified, including older age (adjusted odds ratio [aOR] = 4.28; 95% confidence interval [95% CI]: 4.24-4.32], having a regular health care provider (aOR = 2.39; 95% CI: 2.37-2.41), and being a nonsmoker (aOR = 1.48; 95% CI: 1.47-1.49). Factors associated with decreased likelihood of vaccination included working full time (aOR = 0.72; 95% CI: 0.72-0.72).

Conclusion: Influenza vaccination is still at less than the recommended level in patients with CVD. Future research should consider the impact of interventions to improve vaccination uptake in this population.

Citing Articles

Algorithmic indexing in MEDLINE frequently overlooks important concepts and may compromise literature search results.

Amar-Zifkin A, Ekmekjian T, Paquet V, Landry T J Med Libr Assoc. 2025; 113(1):39-48.

PMID: 39975491 PMC: 11835047. DOI: 10.5195/jmla.2025.1936.


Attitudes, Beliefs, and Self-Reported Rates of Influenza and COVID-19 Vaccinations in the Canadian 2023-2024 National Influenza and Respiratory Viruses Survey.

Sinha S, Iciaszczyk N, Roy B, Boivin W Vaccines (Basel). 2024; 12(11).

PMID: 39591133 PMC: 11598468. DOI: 10.3390/vaccines12111230.


Co-Administration of Influenza and COVID-19 Vaccines: A Cross-Sectional Survey of Canadian Adults' Knowledge, Attitudes, and Beliefs.

Houle S, Johal A, Roumeliotis P, Roy B, Boivin W Pharmacy (Basel). 2024; 12(2).

PMID: 38668096 PMC: 11054434. DOI: 10.3390/pharmacy12020070.


Analysis of Attitudes and Practices towards the Influenza Vaccine in High-Risk Adults in Poland.

Kopciuch D, Hoffmann K, Kus K, Koligat-Seitz A, Ratajczak P, Nowakowska E Vaccines (Basel). 2024; 12(3).

PMID: 38543975 PMC: 10975961. DOI: 10.3390/vaccines12030341.


Knowledge, Perceptions, and Self-Reported Rates of Influenza Immunization among Canadians at High Risk from Influenza: A Cross-Sectional Survey.

Roumeliotis P, Houle S, Johal A, Roy B, Boivin W Vaccines (Basel). 2023; 11(8).

PMID: 37631946 PMC: 10459598. DOI: 10.3390/vaccines11081378.

References
1.
Young K, Gemmill I, Harrison R . Summary of the NACI Seasonal Influenza Vaccine Statement for 2020-2021. Can Commun Dis Rep. 2020; 46(5):132-137. PMC: 7279128. DOI: 10.14745/ccdr.v46i05a06. View

2.
Fitchett D, Theroux P, Brophy J, Cantor W, Cox J, Gupta M . Assessment and management of acute coronary syndromes (ACS): a Canadian perspective on current guideline-recommended treatment--part 1: non-ST-segment elevation ACS. Can J Cardiol. 2011; 27 Suppl A:S387-401. DOI: 10.1016/j.cjca.2011.08.110. View

3.
Chiatti C, Barbadoro P, Lamura G, Pennacchietti L, DI Stanislao F, DErrico M . Influenza vaccine uptake among community-dwelling Italian elderly: results from a large cross-sectional study. BMC Public Health. 2011; 11:207. PMC: 3078885. DOI: 10.1186/1471-2458-11-207. View

4.
van der Wal A, Becker A . Atherosclerotic plaque rupture--pathologic basis of plaque stability and instability. Cardiovasc Res. 1999; 41(2):334-44. DOI: 10.1016/s0008-6363(98)00276-4. View

5.
Williams W, Lu P, OHalloran A, Kim D, Grohskopf L, Pilishvili T . Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014. MMWR Surveill Summ. 2016; 65(1):1-36. DOI: 10.15585/mmwr.ss6501a1. View